These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14501383)

  • 21. p53 elevation in relation to levels and cytotoxicity of mono- and bifunctional melphalan-DNA adducts.
    Gould KA; Nixon C; Tilby MJ
    Mol Pharmacol; 2004 Nov; 66(5):1301-9. PubMed ID: 15308759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of CD98 in melphalan-resistant myeloma cells with reduced drug uptake.
    Harada N; Nagasaki A; Hata H; Matsuzaki H; Matsuno F; Mitsuya H
    Acta Haematol; 2000; 103(3):144-51. PubMed ID: 10940652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The novel alkylating prodrug J1: diagnosis directed activity profile ex vivo and combination analyses in vitro.
    Wickström M; Haglund C; Lindman H; Nygren P; Larsson R; Gullbo J
    Invest New Drugs; 2008 Jun; 26(3):195-204. PubMed ID: 17922077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enhancement of antineoplastic activity of sarcolysin by the means of transforming it into lipid derivative and incorporating into liposomal membranes containing carbohydrate vector].
    Kozlov AM; Korchagina EIu; Vodovozova EL; Bovin NV; Molotkovskiĭ IuL; Syrkin AB
    Biull Eksp Biol Med; 1997 Apr; 123(4):439-41. PubMed ID: 9190189
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel alkylating agent Melflufen induces irreversible DNA damage and cytotoxicity in multiple myeloma cells.
    Ray A; Ravillah D; Das DS; Song Y; Nordström E; Gullbo J; Richardson PG; Chauhan D; Anderson KC
    Br J Haematol; 2016 Aug; 174(3):397-409. PubMed ID: 27098276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effects of 2-chlorodeoxyadenosine and melphalan myeloma cell lines.
    Hjertner O; Börset M; Waage A
    Leuk Res; 1996 Feb; 20(2):155-60. PubMed ID: 8628014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma.
    Mittal S; Song X; Vig BS; Amidon GL
    Pharm Res; 2007 Jul; 24(7):1290-8. PubMed ID: 17377743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acidosis plus melphalan induces nitric oxide-mediated tumor regression in an isolated limb perfusion human melanoma xenograft model.
    Kelley ST; Menon C; Buerk DG; Bauer TW; Fraker DL
    Surgery; 2002 Aug; 132(2):252-8. PubMed ID: 12219020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship between sensitivity of tumor cells to chemotherapeutic agent in vivo and in vitro: experiment with mouse lymphoma cells].
    Li CG; Li ML; Shu XH; Jia YJ; Liu YJ; Li M
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1576-8. PubMed ID: 17785116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antiproliferative action of a melphalan hexapeptide with collagenase-cleavable site.
    Timár F; Botyánszki J; Süli-Vargha H; Babó I; Oláh J; Pogány G; Jeney A
    Cancer Chemother Pharmacol; 1998; 41(4):292-8. PubMed ID: 9488598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.
    Brunstein F; Hoving S; Seynhaeve AL; van Tiel ST; Guetens G; de Bruijn EA; Eggermont AM; ten Hagen TL
    J Natl Cancer Inst; 2004 Nov; 96(21):1603-10. PubMed ID: 15523089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vorinostat enhances the antimyeloma effects of melphalan and bortezomib.
    Campbell RA; Sanchez E; Steinberg J; Shalitin D; Li ZW; Chen H; Berenson JR
    Eur J Haematol; 2010 Mar; 84(3):201-11. PubMed ID: 19929977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel amidine analogue of melphalan as a specific multifunctional inhibitor of growth and metabolism of human breast cancer cells.
    Bielawski K; Bielawska A; Sosnowska K; Miltyk W; Winnicka K; Pałka J
    Biochem Pharmacol; 2006 Jul; 72(3):320-31. PubMed ID: 16730667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proline analogue of melphalan as a prolidase-convertible pro-drug in breast cancer MCF-7 cells.
    Chrzanowski K; Pałka J
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():209-11. PubMed ID: 11820612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA-damage in human cells treated with the closely related alkylating agents peptichemio, m-L-sarcolysin and melphalan.
    Ringborg U; Lambert B; Lewensohn R; Turesson I
    Eur J Cancer Clin Oncol; 1981 Sep; 17(9):991-6. PubMed ID: 7198989
    [No Abstract]   [Full Text] [Related]  

  • 36. Rapid development of glutathione-S-transferase-dependent drug resistance in vitro and its prevention by ethacrynic acid.
    Caffrey PB; Zhu M; Zhang Y; Chinen N; Frenkel GD
    Cancer Lett; 1999 Feb; 136(1):47-52. PubMed ID: 10211938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia.
    Strese S; Hassan SB; Velander E; Haglund C; Höglund M; Larsson R; Gullbo J
    Oncotarget; 2017 Jan; 8(4):6341-6352. PubMed ID: 27974676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agents.
    Biroccio A; Benassi B; Fiorentino F; Zupi G
    Neoplasia; 2004; 6(3):195-206. PubMed ID: 15153331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolidase as a prodrug converting enzyme. III. Synthesis of proline analogues of melphalan and theirs susceptibility to the action of prolidase.
    Bielawska A; Bielawski K; Pałka J
    Rocz Akad Med Bialymst; 1999; 44():190-9. PubMed ID: 10697434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of the N-lost drugs melphalan and bendamustine: synthesis and cytotoxicity of a new set of dendrimer-drug conjugates as tumor therapeutic agents.
    Scutaru AM; Wenzel M; Scheffler H; Wolber G; Gust R
    Bioconjug Chem; 2010 Oct; 21(10):1728-43. PubMed ID: 20849062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.